Prevention of heterotopic ossification after total hip replacement: A prospective comparison of indomethacin and salmon calcitonin in 60 patients

By Günal Izge   Hazer Bülent   Seber Sinan   Göktürk Erol   Turgut Akin   Köse Nusret  

Acta Orthopaedica Scandinavica, Vol. 72, Iss. 5, 2001-10 ,pp. : 467-469

Informa Healthcare

Access to resources Recommend Favorite

Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: A double-blind randomized trial of 100 patients with 1-year follow-up

By Grohs Josef   Schmidt Maximilian   Wanivenhaus Axel  

Acta Orthopaedica, Vol. 78, Iss. 1, 2007-02 ,pp. : 95-98

Informa Healthcare

Access to resources Recommend Favorite

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery

By Neal Bruce C   Rodgers Anthony   Clark Taane   Gray Harley   Reid Ian R   Dunn Louisa   MacMahon Stephen W  

Acta Orthopaedica Scandinavica, Vol. 71, Iss. 2, 2000-04 ,pp. : 122-128

Informa Healthcare

Access to resources Recommend Favorite

Preliminary study of rofecoxib (25 mg) in prevention of heterotopic ossification after total hip replacement

By Franchin F.   Sanguineti F.   Caione G.  

Journal of Orthopaedics and Traumatology, Vol. 5, Iss. 2, 2004-08 ,pp. : 77-80

Springer Publishing Company

Access to resources Recommend Favorite

Heterotopic ossification after total hip replacement and the HLA system in the Sicilian population

By Sessa G.   Costarella L.   Mollica R.   Pavone V.  

Journal of Orthopaedics and Traumatology, Vol. 2, Iss. 3, 2002-06 ,pp. : 125-128

Springer Publishing Company

Access to resources Recommend Favorite